Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.
- DOI
- 10.3322/caac.70105
- Published
- 2026 Jul-Aug
- Container
- CA: a cancer journal for clinicians
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3322/caac.70105,
title = {Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.},
author = {Rooney M and Patel KR and Shah S and Gregg JR and Jay Frank S and Hoffman K and Park R and Hassanzadeh CJ and Choi S and McGuire S and Nguyen QN and Costa DN and Troncoso P and Subudhi SK and Zhao SG and Pettaway CA and Corn P and Tang C and Tran PT},
year = {2026},
journal = {CA: a cancer journal for clinicians},
doi = {10.3322/caac.70105},
url = {https://doi.org/10.3322/caac.70105}
}RIS
TY - JOUR TI - Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer. AU - Rooney M AU - Patel KR AU - Shah S AU - Gregg JR AU - Jay Frank S AU - Hoffman K AU - Park R AU - Hassanzadeh CJ AU - Choi S AU - McGuire S AU - Nguyen QN AU - Costa DN AU - Troncoso P AU - Subudhi SK AU - Zhao SG AU - Pettaway CA AU - Corn P AU - Tang C AU - Tran PT PY - 2026 JO - CA: a cancer journal for clinicians DO - 10.3322/caac.70105 UR - https://doi.org/10.3322/caac.70105 ER -
APA
M, R., KR, P., S, S., JR, G., S, J. F., K, H., R, P., CJ, H., S, C., S, M., QN, N., DN, C., P, T., SK, S., SG, Z., CA, P., P, C., C, T., & PT, T. (2026). Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.. CA: a cancer journal for clinicians. https://doi.org/10.3322/caac.70105
Source records
- pubmed · retrieved 2026-09-25T04:03:40.318Z